You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Microsatellite Instability Low

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neoadjuvant Chemoradiation Therapy, Rectal Cancer, Immunotherapy Trial in Shanghai (xintilimab injection, Control)

Recruiting
  • Neoadjuvant Chemoradiation Therapy
  • +3 more
  • xintilimab injection
  • Control
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery in Changhai Hospital
Aug 5, 2022

Microsatellite Instability in Colorectal Cancers

Completed
  • Colorectal Cancer
  • +4 more
  • Microsatellite instability analysis
  • Istanbul, Turkey
    Sultan 2. Abdulhamid Training and Research Hospital
Dec 5, 2021

Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High Trial in United States

Recruiting
  • Advanced or Metastatic Solid Tumors
  • +11 more
  • Tucson, Arizona
  • +11 more
Dec 2, 2022

MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers Trial in Kashiwa (HRO761,

Recruiting
  • MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
  • Kashiwa, Chiba, Japan
    Novartis Investigative Site
May 2, 2023

Colorectal Cancer Trial in Beijing (IBI310 (anti-CTLA-4 antibody), Sintilimab(anti-PD-1 antibody))

Active, not recruiting
  • Colorectal Cancer
  • IBI310 (anti-CTLA-4 antibody)
  • Sintilimab(anti-PD-1 antibody)
  • Beijing, China
    Beijing cancer hospital
Sep 15, 2022

Colorectal Carcinoma Trial (mFOLFOX6, FOLFIRI, pembrolizumab)

Active, not recruiting
Has Results
  • Colorectal Carcinoma
  • (no location specified)
Oct 28, 2022

Colorectal Cancers With Microsatellite Instability

Active, not recruiting
  • Colorectal Cancer
  • Microsatellite Instability
    • Poitiers, Vienne, France
    • +13 more
    Aug 19, 2022

    Adenocarcinoma - GEJ, Gastric Adenocarcinoma Trial (Dostarlimab)

    Not yet recruiting
    • Adenocarcinoma - GEJ
    • Gastric Adenocarcinoma
    • (no location specified)
    Sep 26, 2023

    Ovarian Cancer, Hepatocellular Carcinoma, NSCLC Trial in Canada, United States (DPX-Survivac, Cyclophosphamide, Pembrolizumab)

    Active, not recruiting
    • Ovarian Cancer
    • +4 more
    • DPX-Survivac
    • +2 more
    • Tucson, Arizona
    • +22 more
    Mar 28, 2022

    Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in ZhengZhou (Cadonilimab

    Not yet recruiting
    • Colorectal Cancer
    • +3 more
    • Cadonilimab (®), a PD-1/CTLA-4 bi-specific antibody
    • ZhengZhou, Henan, China
      Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
    Jun 18, 2023

    Digestive System Cancers Trial in Beijing (KN046, Regorafenib, Apatinib)

    Recruiting
    • Digestive System Cancers
    • Beijing, China
      Peking University Cancer Hospital
    Oct 25, 2023

    Registry Study in MSI/dMMR Solid Tumors

    Not yet recruiting
    • DMMR Cancer
    • +2 more
      • (no location specified)
      Aug 21, 2023

      Advanced Solid Tumors Trial (RO7589831)

      Not yet recruiting
      • Advanced Solid Tumors
      • (no location specified)
      Aug 16, 2023

      Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in Guangzhou (Neoadjuvant

      Recruiting
      • Colorectal Cancer
      • +3 more
      • Neoadjuvant therapy with PD-L1 inhibitor
      • Guangzhou, Guangdong, China
        the Third Affiliated Hospital of Sun Yat-Sen University
      May 10, 2022

      Melanoma, Hepatocellular Carcinoma (HCC), Renal Cell Carcinoma (RCC) Trial (INCB 99280 with Ipilimumab)

      Not yet recruiting
      • Melanoma
      • +5 more
      • INCB 99280 with Ipilimumab
      • (no location specified)
      Jun 9, 2023

      Recurrent/Metastatic Gastric Cancer Trial in Seoul (Nivolumab, Paclitaxel)

      Completed
      • Recurrent/Metastatic Gastric Cancer
      • Nivolumab, Paclitaxel
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      Sep 9, 2022

      Colorectal Cancer Stage IV, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial (Cadonilimab)

      Not yet recruiting
      • Colorectal Cancer Stage IV
      • +2 more
      • (no location specified)
      Jun 19, 2022

      Colorectal Liver Metastases Trial in Nanjing (Radiation: High- and Low-dose radiotherapy, PD-1 Inhibitors)

      Recruiting
      • Colorectal Liver Metastases
      • Radiation: High- and Low-dose radiotherapy
      • PD-1 Inhibitors
      • Nanjing, Jiangsu, China
        Jiangsu Cancer Hospital
      Sep 13, 2023

      Gastric Cancer, Microsatellite Instability Trial in Milan (Durvalumab, Tremelimumab)

      Recruiting
      • Gastric Cancer
      • Microsatellite Instability
      • Milan, Italy
        Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
      Aug 3, 2022

      Colon Adenocarcinoma, High-Frequency Microsatellite Instability, Metastatic Malignant Solid Tumor Trial in Houston

      Active, not recruiting
      • Colon Adenocarcinoma
      • +10 more
      • Anti-PD-L1/TGFbetaRII Fusion Protein M7824
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 12, 2022

      Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +

      Recruiting
      • Gastric Cancer
      • +9 more
      • Tumor Infiltrating Lymphocytes (TIL)
      • Fludarabine + Cyclophosphamide combination
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Jul 21, 2022

      Carcinoma, Renal Cell, Head and Neck Tumor, Skin Tumors Trial in Villejuif (Nivolumab)

      Active, not recruiting
      • Carcinoma, Renal Cell
      • +5 more
      • Villejuif, France
        Gustave Roussy Cancer Campus
      Mar 28, 2022

      Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

      Not yet recruiting
      • Diffuse Astrocytoma, IDH-Mutant
      • +20 more
      • NEO212 Oral Capsule
      • +8 more
      • (no location specified)
      Sep 18, 2023

      Microsatellite Stable Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Toripalimab, High/low-dose radiotherapy)

      Recruiting
      • Microsatellite Stable Metastatic Colorectal Cancer
      • Shanghai, China
        Fudan University Shanghai Cancer Center
      Jul 19, 2023

      Lumbosacral Instability, Low Back Pain Post Partum Trial (Abdominal bracing, clamshell exercise)

      Not yet recruiting
      • Lumbosacral Instability
      • Low Back Pain Post Partum
      • Abdominal bracing
      • clamshell exercise
      • (no location specified)
      Apr 27, 2023